Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coppola, D.
Right arrow Articles by Karl, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coppola, D.
Right arrow Articles by Karl, R. C.

Annals of Surgical Oncology, Vol 6, Issue 3 298-304, Copyright © 1999 by Society of Surgical Oncology

ARTICLES

Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma

D. Coppola, R. H. Schreiber, L. Mora, W. Dalton and R. C. Karl
Department of Pathology, H. Lee Moffitt Cancer and Research Institute and University of South Florida, Tampa 33612, USA.

BACKGROUND: Barrett's esophagus (BE) is a premalignant lesion characterized by replacement of normal squamous epithelium with columnar epithelium. This lesion can progress to dysplasia and adenocarcinoma. Recently, the Fas receptor and retinoblastoma (Rb) protein have been described as important mediators of apoptosis and tumor suppression, respectively. This study was undertaken to examine their expression during the progression of metaplasia to adenocarcinoma in BE. METHODS: In a review of 56 adenocarcinomas arising in BE, the specimen blocks were examined using the immunohistochemical avidin-biotin-peroxidase complex technique. For each specimen, areas of normal epithelium were compared with areas of metaplasia, dysplasia, or carcinoma (when present). Monoclonal mouse anti-human antibodies were used to identify Rb protein (Rb-Ab5, 1/50 dilution; Oncogene Science) and the 40-50-kDa cell membrane Fas protein (APO-1/Fas, 1/5 dilution; DAKO Corp.). RESULTS: Loss of Rb staining was observed as the metaplasia progressed to dysplasia and carcinoma, indicating accumulation of unstainable aberrant protein. Conversely, Fas protein staining was undetectable or weak in normal or metaplastic epithelium, increasing in the areas of high-grade dysplasia and carcinoma. These differences were statistically significant (P < .001). CONCLUSIONS: The accumulation of abnormal Rb protein during the progression of Barrett's metaplasia to carcinoma leads to unsuppressed tumor growth. Fas overexpression may represent a cellular attempt to balance the uncontrolled tumor proliferation by promoting apoptosis.


This article has been cited by other articles:


Home page
 GutHome page
S H Doak, G J S Jenkins, E M Parry, F R D'Souza, A P Griffiths, N Toffazal, V Shah, J N Baxter, and J M Parry
Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus
Gut, May 1, 2003; 52(5): 623 - 628.
[Abstract] [Full Text]

Home page
 Exp. Biol. Med.Home page
Y. Li, J. M. Wo, L. Cai, Z. Zhou, D. Rosenbaum, C. Mendez, M. B. Ray, W. F. Jones, and Y. J. Kang
Association of Metallothionein Expression and Lack of Apoptosis with Progression of Carcinogenesis in Barrett's Esophagus
Experimental Biology and Medicine, March 1, 2003; 228(3): 286 - 292.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.